Abstract:(20 S)-Ginsenoside Rh2 is a natural saponin derived from Panax ginseng Meyer (P. ginseng), which showed significantly potent anticancer properties. However, its low water solubility and bioavailability strongly restrict its pharmaceutical applications. The aim of current research is to develop a modified (20 S)-Ginsenoside Rh2 formulation with high solubility, dissolution rate and bioavailability by combined computational and experimental methodology. The "PharmSD" model was employed to predict the optimal polymer for (20 S)-Ginsenoside Rh2 solid dispersion formulations. The solubility of (20 S)-Ginsenoside Rh2 in various polymers was assessed, and the optimal ternary solid dispersion was evaluated across different dissolution mediums. Characterization techniques included the Powder X-ray diffraction (PXRD) and Fourier transform infrared spectroscopy (FTIR). Molecular dynamics simulations were employed to elucidate the formation mechanism of the solid dispersion and the interactions among active pharmaceutical ingredient (API) and excipient molecules. Cell and animal experiments were conducted to evaluate the in vivo performance of the modified formulation. The "PharmSD" solid dispersion model identified Gelucire 44/14 as the most effective polymer for enhancing the dissolution rate of Rh2. Subsequent experiment also confirmed that Gelucire 44/14 outperformed the other selected polymers. Moreover, the addition of the third component, sodium dodecyl sulfate (SDS), in the ternary solid dispersion formulation significantly amplified dissolution rates than the binary systems. Characterization experiments revealed that the API existed in an amorphous state and interacted via hydrogen bonding with SDS and Gelucire. Moreover, molecular modeling results provided additional evidence of hydrogen bonding interactions between the API and excipient molecules within the optimal ternary solid dispersion. Cell experiments demonstrated efflux ratio (EfR) of Rh2 ternary solid dispersion was lower than that of pure Rh2. In vivo experiments revealed that the modified formulation substantially improved the absorption of Rh2 in rats. Our research successfully developed an optimal ternary solid dispersion for Rh2 with high solubility, dissolution rate and bioavailability by integrated computational and experimental tools. The combination of Artificial Intelligence (AI) technology and molecular dynamics simulation is a wise way to support the future formulation development.

Optimization of Formulation and Preparation of Ginsenoside Rg3 PLGA Nanoparticles

Study on Optimization of Formulation and Preparation Process of Ginsenoside Rg3 Liposomes

Preparation and evaluation of proliposomes formulation for enhancing the oral bioavailability of ginsenosides

Preparation of PEGylated Liposomal Ginsenoside;Formulation Design and in Vitro Evaluation

PEGylation of Ginsenoside Rg3-Entrapped Bovine Serum Albumin Nanoparticles: Preparation, Characterization, and In Vitro Biological Studies

Improvement of Oral Availability of Ginseng Fruit Saponins by a Proliposome Delivery System Containing Sodium Deoxycholate

HPLC-ELSD Method to Determine Encapsulating Efficiency and Loading Capacity of Ginkgolide B in PEG-PLGA Nanoparticles

Preparation and Characterization of Rifampicin Loaded Poly(lactic-Co-glycolic Acid)copolymer Nanoparticles

A Novel Process for One-Step Separation and Cyclodextrin Inclusion of Ginsenoside Rg5 from Ginseng Stem-Leaf Saponins (GSLS): Preparation, Characterization, and Evaluation of Storage Stability and Bioactivity

Recent advances in systemic and local delivery of ginsenosides using nanoparticles and nanofibers

Preparation of icariin/gelatin nanocomposite-PLGA sustained release system and its optimization of technology

Application of Rotatable Central Composite Design in the Preparation and Optimization of Poly (Lactic-Co-glycolic Acid) Nanoparticles for Controlled Delivery of HSA

Optimizing Supercritical Anti-solvent Preparation of Curcumin-Loaded PLGA Nanoparticles by Response Surface Methodology

Preparation and Quality Evaluation of Multi-Nanoparticles Encapsulating Poorly-Soluble Botanical Extracts GRO

Formulation and Process Optimization of Doxorubicin-Loaded PLGA Nanoparticles and Its in Vitro Release

Computer-driven formulation development of Ginsenoside Rh2 ternary solid dispersion

Ginsenoside Drug Nanocomposites Prepared by the Aerosol Solvent Extraction System for Enhancing Drug Solubility and Stability

Preparation of ginseng pills and determination of ginsenoside Re

Methods on Improvements of the Poor Oral Bioavailability of Ginsenosides: Pre-processing, Structural Modification, Drug Combination, and Micro- or Nano- Delivery System

Study on preparation and in vitro characteristics of ginsenoside Rg3 binary solid dispersion]

Preparation and Physicochemical Properties of Ginkgolide PELGE Nanoparticles